131 related articles for article (PubMed ID: 26335682)
1. Use of Recombinant Bone Morphogenetic Protein Is Associated With Reduced Risk of Reoperation After Spine Fusion for Adult Spinal Deformity.
Paul JC; Lonner BS; Vira S; Kaye ID; Errico TJ
Spine (Phila Pa 1976); 2016 Jan; 41(1):E15-21. PubMed ID: 26335682
[TBL] [Abstract][Full Text] [Related]
2. Reoperation Rates After Long Posterior Spinal Fusion: Use of Recombinant Bone Morphogenetic Protein in Idiopathic and Non-idiopathic Scoliosis.
Paul JC; Lonner BS; Vira S; Kaye ID; Errico TJ
Spine Deform; 2016 Jul; 4(4):304-309. PubMed ID: 27927521
[TBL] [Abstract][Full Text] [Related]
3. RhBMP-2 is superior to iliac crest bone graft for long fusions to the sacrum in adult spinal deformity: 4- to 14-year follow-up.
Kim HJ; Buchowski JM; Zebala LP; Dickson DD; Koester L; Bridwell KH
Spine (Phila Pa 1976); 2013 Jun; 38(14):1209-15. PubMed ID: 23392417
[TBL] [Abstract][Full Text] [Related]
4. Does recombinant human bone morphogenetic protein-2 use in adult spinal deformity increase complications and are complications associated with location of rhBMP-2 use? A prospective, multicenter study of 279 consecutive patients.
Bess S; Line BG; Lafage V; Schwab F; Shaffrey CI; Hart RA; Boachie-Adjei O; Akbarnia BA; Ames CP; Burton DC; Deverin V; Fu KM; Gupta M; Hostin R; Kebaish K; Klineberg E; Mundis G; O'Brien M; Shelokov A; Smith JS;
Spine (Phila Pa 1976); 2014 Feb; 39(3):233-42. PubMed ID: 24477081
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of routine use of recombinant human bone morphogenetic protein-2 in occipitocervical and atlantoaxial fusions of the pediatric spine: a minimum of 12 months' follow-up with computed tomography.
Sayama C; Hadley C; Monaco GN; Sen A; Brayton A; Briceño V; Tran BH; Ryan SL; Luerssen TG; Fulkerson D; Jea A
J Neurosurg Pediatr; 2015 Jul; 16(1):14-20. PubMed ID: 25860982
[TBL] [Abstract][Full Text] [Related]
6. Cost-Utility Analysis of rhBMP-2 Use in Adult Spinal Deformity Surgery.
Jain A; Yeramaneni S; Kebaish KM; Raad M; Gum JL; Klineberg EO; Hassanzadeh H; Kelly MP; Passias PG; Ames CP; Smith JS; Shaffrey CI; Bess S; Lafage V; Glassman S; Carreon LY; Hostin RA;
Spine (Phila Pa 1976); 2020 Jul; 45(14):1009-1015. PubMed ID: 32097274
[TBL] [Abstract][Full Text] [Related]
7. Reoperation rates for symptomatic nonunions in posterior cervical (subaxial) fusions with and without bone morphogenetic protein in a cohort of 1158 patients.
Guppy KH; Harris J; Chen J; Paxton EW; Alvarez J; Bernbeck J
J Neurosurg Spine; 2016 Apr; 24(4):556-64. PubMed ID: 26722955
[TBL] [Abstract][Full Text] [Related]
8. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 2: BMP dosage-related complications and long-term outcomes in 509 patients.
Crandall DG; Revella J; Patterson J; Huish E; Chang M; McLemore R
Spine (Phila Pa 1976); 2013 Jun; 38(13):1137-45. PubMed ID: 23354111
[TBL] [Abstract][Full Text] [Related]
9. Long adult spinal deformity fusion to the sacrum using rhBMP-2 versus autogenous iliac crest bone graft.
Maeda T; Buchowski JM; Kim YJ; Mishiro T; Bridwell KH
Spine (Phila Pa 1976); 2009 Sep; 34(20):2205-12. PubMed ID: 19752707
[TBL] [Abstract][Full Text] [Related]
10. Complication rates are reduced for revision adult spine deformity surgery among high-volume hospitals and surgeons.
Paul JC; Lonner BS; Goz V; Weinreb J; Karia R; Toombs CS; Errico TJ
Spine J; 2015 Sep; 15(9):1963-72. PubMed ID: 25937293
[TBL] [Abstract][Full Text] [Related]
11. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 1: Large series diagnosis related outcomes and complications with 2- to 9-year follow-up.
Crandall DG; Revella J; Patterson J; Huish E; Chang M; McLemore R
Spine (Phila Pa 1976); 2013 Jun; 38(13):1128-36. PubMed ID: 23370679
[TBL] [Abstract][Full Text] [Related]
12. A population-based review of bone morphogenetic protein: associated complication and reoperation rates after lumbar spinal fusion.
Savage JW; Kelly MP; Ellison SA; Anderson PA
Neurosurg Focus; 2015 Oct; 39(4):E13. PubMed ID: 26424337
[TBL] [Abstract][Full Text] [Related]
13. Reoperation rates for symptomatic nonunions in posterior cervicothoracic fusions with and without bone morphogenetic protein in a cohort of 450 patients.
Guppy KH; Harris J; Chen J; Paxton EW; Bernbeck JA
J Neurosurg Spine; 2016 Sep; 25(3):309-17. PubMed ID: 27104284
[TBL] [Abstract][Full Text] [Related]
14. Impact of bone morphogenetic proteins on frequency of revision surgery, use of autograft bone, and total hospital charges in surgery for lumbar degenerative disease: review of the Nationwide Inpatient Sample from 2002 to 2008.
Dagostino PR; Whitmore RG; Smith GA; Maltenfort MG; Ratliff JK
Spine J; 2014 Jan; 14(1):20-30. PubMed ID: 23218827
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic protein use in spine surgery in the United States: how have we responded to the warnings?
Guzman JZ; Merrill RK; Kim JS; Overley SC; Dowdell JE; Somani S; Hecht AC; Cho SK; Qureshi SA
Spine J; 2017 Sep; 17(9):1247-1254. PubMed ID: 28456674
[TBL] [Abstract][Full Text] [Related]
16. Nationwide practice patterns in the use of recombinant human bone morphogenetic protein-2 in pediatric spine surgery as a function of patient-, hospital-, and procedure-related factors.
Lam SK; Sayama C; Harris DA; Briceño V; Luerssen TG; Jea A
J Neurosurg Pediatr; 2014 Nov; 14(5):476-85. PubMed ID: 25171721
[TBL] [Abstract][Full Text] [Related]
17. Clinical sequelae after rhBMP-2 use in a minimally invasive transforaminal lumbar interbody fusion.
Singh K; Nandyala SV; Marquez-Lara A; Cha TD; Khan SN; Fineberg SJ; Pelton MA
Spine J; 2013 Sep; 13(9):1118-25. PubMed ID: 24029138
[TBL] [Abstract][Full Text] [Related]
18. Does Reoperation Risk Vary for Different Types of Pediatric Scoliosis?
Paul JC; Lonner BS; Vira S; Feldman D; Errico TJ
J Pediatr Orthop; 2018 Oct; 38(9):459-464. PubMed ID: 27603188
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human bone morphogenetic protein-2-augmented transforaminal lumbar interbody fusion for the treatment of chronic low back pain secondary to the homogeneous diagnosis of discogenic pain syndrome: two-year outcomes.
Corenman DS; Gillard DM; Dornan GJ; Strauch EL
Spine (Phila Pa 1976); 2013 Sep; 38(20):E1269-77. PubMed ID: 23778368
[TBL] [Abstract][Full Text] [Related]
20. Complications of rhBMP-2 utilization for posterolateral lumbar fusions requiring reoperation: a single practice, retrospective case series report.
Hoffmann MF; Jones CB; Sietsema DL
Spine J; 2013 Oct; 13(10):1244-52. PubMed ID: 23973099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
